{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:33:28Z","timestamp":1792661608811,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T00:00:00Z","timestamp":1476835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T00:00:00Z","timestamp":1476835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Drug-induced cholestasis (DIC) is poorly understood and its preclinical prediction is mainly limited to assessing the compound\u2019s potential to inhibit the bile salt export pump (BSEP). Here, we evaluated two 3D spheroid models, one from primary human hepatocytes (PHH) and one from HepaRG cells, for the detection of compounds with cholestatic liability. By repeatedly co-exposing both models to a set of compounds with different mechanisms of hepatotoxicity and a non-toxic concentrated bile acid (BA) mixture for 8 days we observed a selective synergistic toxicity of compounds known to cause cholestatic or mixed cholestatic\/hepatocellular toxicity and the BA mixture compared to exposure to the compounds alone, a phenomenon that was more pronounced after extending the exposure time to 14 days. In contrast, no such synergism was observed after both 8 and 14 days of exposure to the BA mixture for compounds that cause non-cholestatic hepatotoxicity. Mechanisms behind the toxicity of the cholestatic compound chlorpromazine were accurately detected in both spheroid models, including intracellular BA accumulation, inhibition of <jats:italic>ABCB11<\/jats:italic> expression and disruption of the F-actin cytoskeleton. Furthermore, the observed synergistic toxicity of chlorpromazine and BA was associated with increased oxidative stress and modulation of death receptor signalling. Combined, our results demonstrate that the hepatic spheroid models presented here can be used to detect and study compounds with cholestatic liability.<\/jats:p>","DOI":"10.1038\/srep35434","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T10:42:12Z","timestamp":1476873732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":148,"title":["Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability"],"prefix":"10.1038","volume":"6","author":[{"given":"Delilah F. G.","family":"Hendriks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Fredriksson Puigvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Messner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Mortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Ingelman-Sundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,19]]},"reference":[{"key":"BFsrep35434_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.drudis.2008.11.009","volume":"14","author":"JL Stevens","year":"2009","unstructured":"Stevens, J. L. & Baker, T. K. The future of drug safety testing: expanding the view and narrowing the focus. Drug discovery today 14, 162\u2013167, 10.1016\/j.drudis.2008.11.009 (2009).","journal-title":"Drug discovery today"},{"key":"BFsrep35434_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/hep.20800","volume":"42","author":"E Bjornsson","year":"2005","unstructured":"Bjornsson, E. & Olsson, R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 42, 481\u2013489, 10.1002\/hep.20800 (2005).","journal-title":"Hepatology"},{"key":"BFsrep35434_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0300-483X(01)00460-7","volume":"167","author":"C Funk","year":"2001","unstructured":"Funk, C. et al. Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate. Toxicology 167, 83\u201398 (2001).","journal-title":"Toxicology"},{"key":"BFsrep35434_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1124\/mol.59.3.627","volume":"59","author":"C Funk","year":"2001","unstructured":"Funk, C., Ponelle, C., Scheuermann, G. & Pantze, M. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. Molecular pharmacology 59, 627\u2013635 (2001).","journal-title":"Molecular pharmacology"},{"key":"BFsrep35434_CR5","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1002\/jps.23584","volume":"102","author":"K Yang","year":"2013","unstructured":"Yang, K., Kock, K., Sedykh, A., Tropsha, A. & Brouwer, K. L. An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters. Journal of pharmaceutical sciences 102, 3037\u20133057, 10.1002\/jps.23584 (2013).","journal-title":"Journal of pharmaceutical sciences"},{"key":"BFsrep35434_CR6","doi-asserted-by":"publisher","first-page":"G734","DOI":"10.1152\/ajpgi.00491.2002","volume":"284","author":"H Higuchi","year":"2003","unstructured":"Higuchi, H. & Gores, G. J. Bile acid regulation of hepatic physiology: IV. Bile acids and death receptors. American journal of physiology. Gastrointestinal and liver physiology 284, G734\u2013G738, 10.1152\/ajpgi.00491.2002 (2003).","journal-title":"American journal of physiology. Gastrointestinal and liver physiology"},{"key":"BFsrep35434_CR7","doi-asserted-by":"crossref","unstructured":"Stieger, B. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Handbook of experimental pharmacology, 205\u2013259, 10.1007\/978-3-642-14541-4_5 (2011).","DOI":"10.1007\/978-3-642-14541-4_5"},{"key":"BFsrep35434_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","volume":"118","author":"RE Morgan","year":"2010","unstructured":"Morgan, R. E. et al. Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol Sci 118, 485\u2013500, 10.1093\/toxsci\/kfq269 (2010).","journal-title":"Toxicol Sci"},{"key":"BFsrep35434_CR9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1124\/dmd.109.028407","volume":"38","author":"JH Ansede","year":"2010","unstructured":"Ansede, J. H., Smith, W. R. & Perry, C. H., St Claire, R. L., 3rd & Brouwer, K. R. An in vitro assay to assess transporter-based cholestatic hepatotoxicity using sandwich-cultured rat hepatocytes. Drug Metabolism and Disposition 38, 276\u2013280, 10.1124\/dmd.109.028407 (2010).","journal-title":"Drug Metabolism and Disposition"},{"key":"BFsrep35434_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/toxsci\/kfn268","volume":"108","author":"Y Alnouti","year":"2009","unstructured":"Alnouti, Y. Bile Acid sulfation: a pathway of bile acid elimination and detoxification. Toxicol Sci 108, 225\u2013246, 10.1093\/toxsci\/kfn268 (2009).","journal-title":"Toxicol Sci"},{"key":"BFsrep35434_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.pharmthera.2010.03.005","volume":"126","author":"G Zollner","year":"2010","unstructured":"Zollner, G., Wagner, M. & Trauner, M. Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity. Pharmacol Therapeut 126, 228\u2013243, 10.1016\/j.pharmthera.2010.03.005 (2010).","journal-title":"Pharmacol Therapeut"},{"key":"BFsrep35434_CR12","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/hep.21359","volume":"44","author":"C Pauli-Magnus","year":"2006","unstructured":"Pauli-Magnus, C. & Meier, P. J. Hepatobiliary transporters and drug-induced cholestasis. Hepatology 44, 778\u2013787, 10.1002\/hep.21359 (2006).","journal-title":"Hepatology"},{"key":"BFsrep35434_CR13","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/hep.24229","volume":"53","author":"MS Padda","year":"2011","unstructured":"Padda, M. S., Sanchez, M., Akhtar, A. J. & Boyer, J. L. Drug-induced cholestasis. Hepatology 53, 1377\u20131387, 10.1002\/hep.24229 (2011).","journal-title":"Hepatology"},{"key":"BFsrep35434_CR14","unstructured":"Heslop, J. A. et al. Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile. Arch Toxicol, 10.1007\/s00204-016-1694-y (2016)."},{"key":"BFsrep35434_CR15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3109\/03602530903491881","volume":"42","author":"B Swift","year":"2010","unstructured":"Swift, B., Pfeifer, N. D. & Brouwer, K. L. Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev 42, 446\u2013471, 10.3109\/03602530903491881 (2010).","journal-title":"Drug Metab Rev"},{"key":"BFsrep35434_CR16","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/hep.26414","volume":"58","author":"C Rowe","year":"2013","unstructured":"Rowe, C. et al. Proteome-wide analyses of human hepatocytes during differentiation and dedifferentiation. Hepatology 58, 799\u2013809, 10.1002\/hep.26414 (2013).","journal-title":"Hepatology"},{"key":"BFsrep35434_CR17","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1083\/jcb.101.3.914","volume":"101","author":"J Landry","year":"1985","unstructured":"Landry, J., Bernier, D., Ouellet, C., Goyette, R. & Marceau, N. Spheroidal aggregate culture of rat liver cells: histotypic reorganization, biomatrix deposition, and maintenance of functional activities. The Journal of cell biology 101, 914\u2013923 (1985).","journal-title":"The Journal of cell biology"},{"key":"BFsrep35434_CR18","doi-asserted-by":"crossref","unstructured":"Bell, C. C. et al. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Scientific reports 6, 25187, 10.1038\/srep25187 (2016).","DOI":"10.1038\/srep25187"},{"key":"BFsrep35434_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00204-012-0968-2","volume":"87","author":"S Messner","year":"2013","unstructured":"Messner, S., Agarkova, I., Moritz, W. & Kelm, J. M. Multi-cell type human liver microtissues for hepatotoxicity testing. Archives of toxicology 87, 209\u2013213, 10.1007\/s00204-012-0968-2 (2013).","journal-title":"Archives of toxicology"},{"key":"BFsrep35434_CR20","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/hep.24760","volume":"55","author":"RM Tostoes","year":"2012","unstructured":"Tostoes, R. M. et al. Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing. Hepatology 55, 1227\u20131236, 10.1002\/hep.24760 (2012).","journal-title":"Hepatology"},{"key":"BFsrep35434_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.vascn.2010.04.013","volume":"63","author":"M Lubberstedt","year":"2011","unstructured":"Lubberstedt, M. et al. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro. Journal of pharmacological and toxicological methods 63, 59\u201368, 10.1016\/j.vascn.2010.04.013 (2011).","journal-title":"Journal of pharmacological and toxicological methods"},{"key":"BFsrep35434_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/toxsci\/kfv041","volume":"145","author":"P Bachour-El Azzi","year":"2015","unstructured":"Bachour-El Azzi, P. et al. Comparative Localization and Functional Activity of the Main Hepatobiliary Transporters in HepaRG Cells and Primary Human Hepatocytes. Toxicological sciences: an official journal of the Society of Toxicology 145, 157\u2013168, 10.1093\/toxsci\/kfv041 (2015).","journal-title":"Toxicological sciences: an official journal of the Society of Toxicology"},{"key":"BFsrep35434_CR23","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/hep.26160","volume":"57","author":"S Antherieu","year":"2013","unstructured":"Antherieu, S. et al. Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells. Hepatology 57, 1518\u20131529, 10.1002\/hep.26160 (2013).","journal-title":"Hepatology"},{"key":"BFsrep35434_CR24","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1124\/dmd.114.058123","volume":"42","author":"P Bachour-El Azzi","year":"2014","unstructured":"Bachour-El Azzi, P. et al. Impact of inflammation on chlorpromazine-induced cytotoxicity and cholestatic features in HepaRG cells. Drug metabolism and disposition: the biological fate of chemicals 42, 1556\u20131566, 10.1124\/dmd.114.058123 (2014).","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"key":"BFsrep35434_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/toxsci\/kfu122","volume":"141","author":"A Sharanek","year":"2014","unstructured":"Sharanek, A. et al. Different dose-dependent mechanisms are involved in early cyclosporine a-induced cholestatic effects in hepaRG cells. Toxicol Sci 141, 244\u2013253, 10.1093\/toxsci\/kfu122 (2014).","journal-title":"Toxicol Sci"},{"key":"BFsrep35434_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/toxsci\/kft021","volume":"133","author":"P Gunness","year":"2013","unstructured":"Gunness, P. et al. 3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies. Toxicological sciences: an official journal of the Society of Toxicology 133, 67\u201378, 10.1093\/toxsci\/kft021 (2013).","journal-title":"Toxicological sciences: an official journal of the Society of Toxicology"},{"key":"BFsrep35434_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.taap.2013.10.032","volume":"274","author":"S Chatterjee","year":"2014","unstructured":"Chatterjee, S., Richert, L., Augustijns, P. & Annaert, P. Hepatocyte-based in vitro model for assessment of drug-induced cholestasis. Toxicology and applied pharmacology 274, 124\u2013136, 10.1016\/j.taap.2013.10.032 (2014).","journal-title":"Toxicology and applied pharmacology"},{"key":"BFsrep35434_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.tiv.2016.03.008","volume":"34","author":"M Oorts","year":"2016","unstructured":"Oorts, M. et al. Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes. Toxicology in vitro: an international journal published in association with BIBRA 34, 179\u2013186, 10.1016\/j.tiv.2016.03.008 (2016).","journal-title":"Toxicology in vitro: an international journal published in association with BIBRA"},{"key":"BFsrep35434_CR29","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/0016-5085(95)90585-5","volume":"109","author":"RJ Sokol","year":"1995","unstructured":"Sokol, R. J., Winklhofer-Roob, B. M., Devereaux, M. W. & McKim, J. M., Jr. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology 109, 1249\u20131256 (1995).","journal-title":"Gastroenterology"},{"key":"BFsrep35434_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10059-009-0050-y","volume":"27","author":"FX Soriano","year":"2009","unstructured":"Soriano, F. X. et al. Transcriptional regulation of the AP-1 and Nrf2 target gene sulfiredoxin. Molecules and cells 27, 279\u2013282, 10.1007\/s10059-009-0050-y (2009).","journal-title":"Molecules and cells"},{"key":"BFsrep35434_CR31","doi-asserted-by":"publisher","first-page":"38610","DOI":"10.1074\/jbc.M105300200","volume":"276","author":"H Higuchi","year":"2001","unstructured":"Higuchi, H. et al. The bile acid glycochenodeoxycholate induces trail-receptor 2\/DR5 expression and apoptosis. The Journal of biological chemistry 276, 38610\u201338618, 10.1074\/jbc.M105300200 (2001).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep35434_CR32","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1124\/dmd.113.054205","volume":"42","author":"AD Rodrigues","year":"2014","unstructured":"Rodrigues, A. D. et al. Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump. Drug Metabolism and Disposition 42, 566\u2013574, 10.1124\/dmd.113.054205 (2014).","journal-title":"Drug Metabolism and Disposition"},{"key":"BFsrep35434_CR33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/toxsci\/kft176","volume":"136","author":"RE Morgan","year":"2013","unstructured":"Morgan, R. E. et al. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicol Sci 136, 216\u2013241, 10.1093\/toxsci\/kft176 (2013).","journal-title":"Toxicol Sci"},{"key":"BFsrep35434_CR34","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.ajpath.2013.07.012","volume":"183","author":"B Bhushan","year":"2013","unstructured":"Bhushan, B. et al. Role of bile acids in liver injury and regeneration following acetaminophen overdose. The American journal of pathology 183, 1518\u20131526, 10.1016\/j.ajpath.2013.07.012 (2013).","journal-title":"The American journal of pathology"},{"key":"BFsrep35434_CR35","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1124\/mol.112.081752","volume":"83","author":"T Yoshikado","year":"2013","unstructured":"Yoshikado, T. et al. Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolites. Mol Pharmacol 83, 552\u2013562, 10.1124\/mol.112.081752 (2013).","journal-title":"Mol Pharmacol"},{"key":"BFsrep35434_CR36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1345\/aph.1A406","volume":"37","author":"YD Skurnik","year":"2003","unstructured":"Skurnik, Y. D., Tcherniak, A., Edlan, K. & Sthoeger, Z. Ticlopidine-induced cholestatic hepatitis. The Annals of pharmacotherapy 37, 371\u2013375 (2003).","journal-title":"The Annals of pharmacotherapy"},{"key":"BFsrep35434_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/sj.tpj.6500442","volume":"8","author":"K Hirata","year":"2008","unstructured":"Hirata, K. et al. Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case-control study. The pharmacogenomics journal 8, 29\u201333, 10.1038\/sj.tpj.6500442 (2008).","journal-title":"The pharmacogenomics journal"},{"key":"BFsrep35434_CR38","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1124\/dmd.113.054189","volume":"42","author":"B Garzel","year":"2014","unstructured":"Garzel, B. et al. The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity. Drug Metabolism and Disposition 42, 318\u2013322, 10.1124\/dmd.113.054189 (2014).","journal-title":"Drug Metabolism and Disposition"},{"key":"BFsrep35434_CR39","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1053\/jhep.2000.20519","volume":"32","author":"MG Roma","year":"2000","unstructured":"Roma, M. G., Milkiewicz, P., Elias, E. & Coleman, R. Control by signaling modulators of the sorting of canalicular transporters in rat hepatocyte couplets: role of the cytoskeleton. Hepatology 32, 1342\u20131356, 10.1053\/jhep.2000.20519 (2000).","journal-title":"Hepatology"},{"key":"BFsrep35434_CR40","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/toxsci\/71.2.276","volume":"71","author":"ID Roman","year":"2003","unstructured":"Roman, I. D., Fernandez-Moreno, M. D., Fueyo, J. A., Roma, M. G. & Coleman, R. Cyclosporin A induced internalization of the bile salt export pump in isolated rat hepatocyte couplets. Toxicological sciences: an official journal of the Society of Toxicology 71, 276\u2013281 (2003).","journal-title":"Toxicological sciences: an official journal of the Society of Toxicology"},{"key":"BFsrep35434_CR41","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1124\/dmd.113.056549","volume":"42","author":"P Chen","year":"2014","unstructured":"Chen, P. et al. Low dose of oleanolic acid protects against lithocholic acid-induced cholestasis in mice: potential involvement of nuclear factor-E2-related factor 2-mediated upregulation of multidrug resistance-associated proteins. Drug Metabolism and Disposition 42, 844\u2013852, 10.1124\/dmd.113.056549 (2014).","journal-title":"Drug Metabolism and Disposition"},{"key":"BFsrep35434_CR42","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1124\/mol.107.039370","volume":"72","author":"KP Tan","year":"2007","unstructured":"Tan, K. P., Yang, M. & Ito, S. Activation of nuclear factor (erythroid-2 like) factor 2 by toxic bile acids provokes adaptive defense responses to enhance cell survival at the emergence of oxidative stress. Molecular pharmacology 72, 1380\u20131390, 10.1124\/mol.107.039370 (2007).","journal-title":"Molecular pharmacology"},{"key":"BFsrep35434_CR43","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/hep.21831","volume":"46","author":"JM Maher","year":"2007","unstructured":"Maher, J. M. et al. Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology 46, 1597\u20131610, 10.1002\/hep.21831 (2007).","journal-title":"Hepatology"},{"key":"BFsrep35434_CR44","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1152\/physrev.00027.2002","volume":"83","author":"M Trauner","year":"2003","unstructured":"Trauner, M. & Boyer, J. L. Bile salt transporters: molecular characterization, function, and regulation. Physiological reviews 83, 633\u2013671, 10.1152\/physrev.00027.2002 (2003).","journal-title":"Physiological reviews"},{"key":"BFsrep35434_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1074\/jbc.M309476200","volume":"279","author":"H Higuchi","year":"2004","unstructured":"Higuchi, H., Grambihler, A., Canbay, A., Bronk, S. F. & Gores, G. J. Bile acids up-regulate death receptor 5\/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1. The Journal of biological chemistry 279, 51\u201360, 10.1074\/jbc.M309476200 (2004).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep35434_CR46","doi-asserted-by":"publisher","first-page":"G992","DOI":"10.1152\/ajpgi.2000.278.6.G992","volume":"278","author":"T Sodeman","year":"2000","unstructured":"Sodeman, T., Bronk, S. F., Roberts, P. J., Miyoshi, H. & Gores, G. J. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. American journal of physiology. Gastrointestinal and liver physiology 278, G992\u2013G999 (2000).","journal-title":"American journal of physiology. Gastrointestinal and liver physiology"},{"key":"BFsrep35434_CR47","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1124\/dmd.111.040758","volume":"40","author":"S Dawson","year":"2012","unstructured":"Dawson, S., Stahl, S., Paul, N., Barber, J. & Kenna, J. G. In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug Metabolism and Disposition 40, 130\u2013138, 10.1124\/dmd.111.040758 (2012).","journal-title":"Drug Metabolism and Disposition"},{"key":"BFsrep35434_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jchromb.2009.11.019","volume":"878","author":"X Xiang","year":"2010","unstructured":"Xiang, X. et al. High performance liquid chromatography-tandem mass spectrometry for the determination of bile acid concentrations in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 878, 51\u201360, 10.1016\/j.jchromb.2009.11.019 (2010).","journal-title":"Journal of chromatography. B, Analytical technologies in the biomedical and life sciences"},{"key":"BFsrep35434_CR49","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/toxsci\/kft223","volume":"137","author":"F Gustafsson","year":"2014","unstructured":"Gustafsson, F., Foster, A. J., Sarda, S., Bridgland-Taylor, M. H. & Kenna, J. G. A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humans. Toxicol Sci 137, 189\u2013211, 10.1093\/toxsci\/kft223 (2014).","journal-title":"Toxicol Sci"},{"key":"BFsrep35434_CR50","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1002\/pds.1804","volume":"18","author":"JS Floyd","year":"2009","unstructured":"Floyd, J. S., Barbehenn, E., Lurie, P. & Wolfe, S. M. Case series of liver failure associated with rosiglitazone and pioglitazone. Pharmacoepidemiology and drug safety 18, 1238\u20131243, 10.1002\/pds.1804 (2009).","journal-title":"Pharmacoepidemiology and drug safety"},{"key":"BFsrep35434_CR51","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/hep.1840080513","volume":"8","author":"E Freneaux","year":"1988","unstructured":"Freneaux, E. et al. Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic. Hepatology 8, 1056\u20131062 (1988).","journal-title":"Hepatology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep35434.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep35434","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep35434.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:15:51Z","timestamp":1672877751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep35434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,19]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,16]]}},"alternative-id":["BFsrep35434"],"URL":"https:\/\/doi.org\/10.1038\/srep35434","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,19]]},"assertion":[{"value":"15 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35434"}}